Sorrento Therapeutics

16 Decision Makers Β· 20 Verified Contacts & Email Format

πŸ“ San Diego, CAPharmaceuticalsπŸ—“ Est. 2006πŸ‘₯ 101–250 employees

About Sorrento Therapeutics

Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.

Email Format

{first_letter_first_name}{last_name}@sorrentotherapeutics.com β€” 100.0%

ssmith@sorrentotherapeutics.com

Leadership & Decision Makers

Contact details of 16 Sorrento Therapeutics decision makers

Jaisim Shah

President & Chief Executive Officer
  • Work email

    j***h@sorrentotherapeutics.com

Dean Ferrigno

Vice President Of Finance
  • Work email

    d*******o@sorrentotherapeutics.com

Ryan Tang

It Director
  • Work email

    r***g@sorrentotherapeutics.com

Dindo Sy Chu

Vice President Finance LinkedIn
  • Work email

    d**u@sorrentotherapeutics.com

Hua Huang

Director LinkedIn
  • Work email

    h****g@sorrentotherapeutics.com

Mark Brunswick

SVP Head of Regulatory Affairs and Quality LinkedIn
  • Work email

    m********k@sorrentotherapeutics.com

Silvia Chang

Head of Small Molecule Program Management/Executive Director Program Management LinkedIn
  • Work email

    s****g@sorrentotherapeutics.com

Jiong Shao

CFO, Executive VP

Robert Allen

Vice President Antiviral and oncolytic immunotherapy development

David Miao

Chief Technology Officer

Richard G. Vincent

Director, Chief Financial Officer

Henry Ji

Co-Founder, President, Chief Executive Officer & Chairman

Yu Zhou

Senior Vice President

Thomas Wolf

Executive Vice President

Jerry Zeldis

CMO

Hong Zhang, Ph.D

Executive Director

Team & Specialists

Contact details of 4 Sorrento Therapeutics team members

Yan Li

Senior Scientist, Antibody Technology Development LinkedIn
  • Work email

    y*i@sorrentotherapeutics.com

Vanessa Mendez

Quality LinkedIn
  • Work email

    v*****z@sorrentotherapeutics.com

Meredith Childers

Senior Writer
  • Work email

    m*******s@sorrentotherapeutics.com

Emmy Bashi

Manager, SEC Reporting,Senior Accountant

General Emails

General company emails, e.g. customer support lines

    info@sorrentotherapeutics.com

    General Inquiries

    admin@sorrentotherapeutics.com

    Admin Team

    manager@sorrentotherapeutics.com

    Management Department

    legal@sorrentotherapeutics.com

    Legal Department

    investoren@sorrentotherapeutics.com

    Unclassified inbox

    doanh@sorrentotherapeutics.com

    Unclassified inbox

    investisseurs@sorrentotherapeutics.com

    Unclassified inbox

Similar Companies like Sorrento Therapeutics

Rakuten Medical

rakuten-med.com
Pharmaceuticals Β· San Diego, CA Β· Est. 2010 Β· 101–250 employees

HQ: San Diego, CA

Jazz Pharmaceuticals

jazzpharma.com
Biotechnology Β· Palo Alto, CA Β· Est. 2003 Β· 501–1000 employees Β· $500M–$1B

HQ: Palo Alto, CA

Loxo Oncology

loxooncology.com
Pharmaceuticals Β· New York, NY Β· Est. 2013 Β· 501–1000 employees

HQ: New York, NY

Indivior

indivior.com
Biotechnology Β· Richmond, VA Β· Est. 2014 Β· 501–1000 employees

HQ: Richmond, VA

Moderna

modernatx.com
Biotechnology Β· Cambridge, MA Β· Est. 2010 Β· 1001–5000 employees

HQ: Cambridge, MA

Explore similar firms in the Pharmaceuticals sector

Company Info

Last updated: 27/07/2025

(858) 210-3759

San Diego, CA

Specialization: Biopharmaceutical,
Legal Name: Sorrento Therapeutics, Inc.
Business Type: Public
Employees: 101-250
Rounds: Post-IPO Equity
Founded Date: 2006
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:SRNE
Operating Status: Active
Last Funding Type: Post-IPO Equity
Phone Number: (858) 210-3759
Sub-Organization of: Sorrento Therapeutics
Last Investment Activity: Feb 27, 2024
Investments Activity: Feb 27, 2024 Feb 21, 2024 Jul 21, 2023

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.